E

EYEN

Eyenovia Inc

1.09

-0.04-3.54%
After Hours: 1.090  0.00  0.00%16:56 04/25 EDT
1D
5D
Daily
Weekly
Monthly
Quarterly
Yearly
OPEN/PREV CLOSE1.140/1.130
TODAY RANGE1.050-1.158
VOL25.64K
MARKET CAP3.09M
52 WEEK RANGE0.8500-124.80
AVG VOL (3M)268.35K
% TURNOVER0.91%
TURNOVER--
P/E (TTM)-0.0182
% RANGE9.59%
EPS(TTM)-59.8060
P/E(FORWARD)-0.0675
P/B-0.1254
BVPS-8.6937
DIVIDEND--
P/S28.61
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP2.26M
SHARES OUTSTANDING2.83M
NEXT EARNINGS05/13-05/19
FREE FLOAT2.08M
LOT SIZE1
EX-DIV DATE02/03/2025
Same Industry
Name/Symbol
Change%
Price

E

Eyenovia Inc

EYEN

-3.54%
1.09

M

McKesson

MCK

+0.95%
695.00

B

Biogen Inc

BIIB

-0.56%
118.84

A

Amgen Inc

AMGN

+0.36%
280.84

S

Shire

SHPG

--
179.20

B

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

-1.69%
0.0290

L

Lilly Eli & Co

LLY

+2.89%
884.54

C

Celgene

CELG

--
108.24

T

Therapeuticsmd Inc

TXMD

+0.88%
1.15

J

Johnson & Johnson

JNJ

-0.23%
154.58

A

Abbvie Inc

ABBV

+3.15%
186.06

Z

Zoetis Inc

ZTS

+0.77%
153.47

G

Gilead Sciences Inc

GILD

-2.81%
103.17

N

Novo-Nordisk A/S

NVO

-0.88%
62.08

B

Bristol-Myers Squibb Co

BMY

-1.62%
47.90

A

Alexion Pharms

ALXN

+1.70%
182.50

P

Pfizer

PFE

+0.61%
22.92

S

Sanofi FR

SNY

-2.28%
52.32

S

Sanofi FR

GCVRZ

0.00%
0.8711

N

Novartis

NVS

+0.87%
112.14

D

Dr Reddys Labs

RDY

-1.50%
13.79
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit:  https://www.webull.hk/pricing
More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.